Medigene AG
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Medigene AG generated cash of -$15,119,000, which is less than the previous year. Cash used in financing activities reached the amount of -$776,000 last year. Net change in cash is therefore -$13,550,000.
Cash Flow
| 2014 | -8.75M | -935K | 14.50M |
|---|---|---|---|
| 2015 | -10.60M | -39.40M | 43.79M |
| 2016 | -3.75M | 9.86M | -231K |
| 2017 | -20.84M | 15.21M | 18.72M |
| 2018 | -10.14M | -19.47M | 29.29M |
| 2019 | -16.42M | 24.16M | -469K |
| 2020 | -24.78M | 21.11M | -826K |
| 2021 | -10.75M | 4.02M | -1.03M |
| 2022 | 11.97M | -12.00M | -282K |
| 2023 | -15.11M | 2.38M | -776K |
0QGJ.L Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 22.22M | 22.41M | 30.03M | 34.68M | 27.40M | 27.72M | 14.63M | 8.75M | 14.97M | 10.16M |
Operating activities | ||||||||||
Net income | -16.17M | -8.33M | -9.98M | -28.87M | -19.96M | -21.22M | -13.57M | -9.49M | -12.99M | -5.75M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 1.46M | 21.85M | 3.42M | 6.47M | 2.37M | 1.57M | 1.26M | 845K | 942K | 810K |
Stock-based compensation expense | 307K | 350K | 651K | 662K | 492K | 0 | 104K | 326K | 111K | 66K |
| Deferred income tax benefit | 307K | 350K | 651K | 662K | 492K | 0 | 104K | 326K | 111K | 66K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 2.56M | -2.28M | 914K | 2.65M | 341K | 605K | -168K | -227K | 2.54M | -2.66M |
Inventories | 0 | 0 | 0 | 0 | 305K | 426K | 142K | -1.21M | -2.24M | -1.36M |
Accounts payable | 0 | 137K | 65K | -939K | 15K | 633K | -248K | -381K | -431K | 0 |
Cash generated by operating activities | -15.11M | 11.97M | -10.75M | -24.78M | -16.42M | -10.14M | -20.84M | -3.75M | -10.60M | -8.75M |
Investing activities | ||||||||||
Purchases Of Investments | -3.04M | -11M | -4.15M | 0 | 0 | -20M | -14.51M | -10.58M | -38.08M | 0 |
Investments In Property Plant And Equipment | -664K | -1.00M | -125K | -484K | -1.42M | -1.01M | -1.56M | -1.72M | -1.32M | -873K |
Acquisitions Net | 0 | 2K | 33K | 24K | 0 | 4K | 31K | 46K | 0 | 0 |
Cash generated by investing activities | 2.38M | -12.00M | 4.02M | 21.11M | 24.16M | -19.47M | 15.21M | 9.86M | -39.40M | -935K |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 21K | 30.02M | 19.32M | 0 | 46.43M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -43.79M | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -77K | -2.73M | 0 |
Repayments of term debt | -171K | -171K | -191K | -284K | -1.24M | -730K | -688K | -196K | 102K | 0 |
Cash used in financing activities | -776K | -282K | -1.03M | -826K | -469K | 29.29M | 18.72M | -231K | 43.79M | 14.50M |
Net Change In Cash | -13.55M | -193K | -7.61M | -4.64M | 7.27M | -316K | 13.09M | 5.87M | -6.21M | 4.81M |
Cash at end of period | 8.67M | 22.22M | 22.41M | 30.03M | 34.68M | 27.40M | 27.72M | 14.63M | 8.75M | 14.97M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |